Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 228,242 shares at $50.24 ($11.6M) on 2022-03-25, disclosed to the SEC on 2022-03-29.
Open-market sale of $11.6M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.24 | 4,514 | $227K | 2.0% |
| 2 | $50.24 | 4,514 | $227K | 2.0% |
| 3 | $50.24 | 31,710 | $1.6M | 13.8% |
| 4 | $50.24 | 31,710 | $1.6M | 13.8% |
| 5 | $50.82 | 5,294 | $269K | 2.3% |
| 6 | $50.82 | 5,294 |
| $269K |
| 2.3% |
| 7 | $50.82 | 37,195 | $1.9M | 16.3% |
| 8 | $50.82 | 37,195 | $1.9M | 16.3% |
| 9 | $50.89 | 4,412 | $225K | 1.9% |
| 10 | $50.89 | 4,412 | $225K | 1.9% |
| 11 | $50.89 | 30,996 | $1.6M | 13.6% |
| 12 | $50.89 | 30,996 | $1.6M | 13.6% |
| Total | $50.66 avg | 228,242 | $11.6M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |